Presynaptic cannabinoid type 1 receptors (CB1Rs) are major mediators of retrograde synaptic plasticity at both excitatory and inhibitory synapses and participate in a plethora of physiological functions. Whether presynaptic receptors, such as CB1R, display functionally relevant movements at the surface of neuronal membranes is not known. We analyzed the lateral mobility of native CB1Rs in cortical neurons by using single-quantum dot imaging. We found that CB1Rs are highly mobile and rapidly diffuse in and out of presynapses. Agonist-induced desensitization correlated with a reduction in the fraction of surface CB1Rs and a drastic decrease in the membrane dynamic of the CB1Rs that remained at the presynaptic surface. Desensitization specifically excluded CB1Rs from synapses and increased the fraction of immobile receptors in the extrasynaptic compartment. The results suggest that decrease of mobility may be one of the core mechanisms underlying the desensitization of CB1R, the most abundant G protein-coupled receptor in the brain.
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receptor mobility ͉ CB1R ͉ G-protein coupled receptor C annabinoid type 1 receptors (CB1Rs) and endocannabinoids (eCBs), as well as their synthesizing and degrading enzymes, constitute the eCB system (1, 2) . In the CNS, the eCB system mediates retrograde signaling: postsynaptically produced eCBs cross the synapses and activate presynaptic CB1Rs (3) . In addition to exocytosis/endocytosis, neurotransmitter receptor movement into and out of synapses may be one of the core mechanisms for rapidly changing the number of functional postsynaptic receptors (4, 5) . Curiously, the lateral movements of presynaptic receptors, such as CB1Rs, have never been studied.
Determining whether CB1Rs diffuse in presynaptic membranes, similarly to postsynaptic ionotropic receptors (5) , is necessary to understand the molecular logic of the eCB system (1) . Because CB1Rs must be within reaching distance of eCBs to fulfill their presynaptic functions (3), surface diffusion potentially represents an efficient and rapid means of modulating retrograde signaling. CB1Rs are classical G protein-coupled receptors (GPCRs), and prolonged agonist treatment triggers both internalization via the clathrin-coated pit pathway (ref. 6 , but see ref. 7 ) and uncoupling from their effector G proteins. A single in vivo exposure to ⌬ 9 -tetrahydrocannabinol abolishes eCB-mediated retrograde signaling and reduces the CB1R maximal efficacy without modifying total binding or coupling (8) . Thus, another mechanism must exist to functionally desensitize CB1Rs in response to agonist exposure. A tantalizing hypothesis is that CB1Rs are moved away from their presynaptic site of actions following agonist exposure.
Here, we analyzed the surface mobility of native CB1Rs in cortical neurons in vitro by using single-quantum dot imaging (9) . Our data support the idea that the dynamic exclusion of CB1Rs from a particular presynaptic subdomain might play a prominent role in the desensitization of the most abundant GPCRs in the brain.
GluR2-containing AMPA receptors (AMPARs; 0.2 Ϯ 0.05 s, n ϭ 24, and 1.3 Ϯ 0.4 s, n ϭ 20, respectively; see Fig. 4B ) (12, 13) , likely due to differences in the environment of presynaptic CB1Rs and postsynaptic GluR2-containing AMPARs.
A comparison of the distribution of diffusion coefficients of the global population of CB1Rs (i.e., mobile and immobile) revealed no difference between the mobility of synaptic and extrasynaptic CB1Ra [extrasynaptic: median ϭ 0.213 m 2 /s, interquartile range (IQR; 25-75%) ϭ 0.019-0.405 m 2 /s, n ϭ 1,072; synaptic: median ϭ 0.182 m 2 /s, IQR ϭ 0.02-0.42 m 2 /s, n ϭ 30; P Ͼ 0.05; Fig. 1D ). Compared with other neurotransmitter receptors, the diffusion coefficients of CB1R and AM-PAR were similar (14 (Fig. 1E) . In contrast, the MSD values of CB1Rs within the spatially restricted synaptic subdomain reflected spatially confined movement (Fig. 1E) .
Desensitization Dramatically Reduces the Fraction of Mobile CB1Rs. In rodents, subchronic activation of CB1Rs strongly desensitizes CB1Rs (15, 16) . In animal and cellular models, CB1R desensitization is achieved easily by prolonged treatment with a CB agonist (17) (18) (19) . Cortical neurons were treated with the synthetic In contrast, prolonged treatment with the cannabinoid agonist led to a large increase in the fraction of immobile CB1Rs. Chronic incubation with AM281, a described antagonist with inverse agonist properties, had no effect on the fraction of immobile CB1Rs (Fig. 2B) . After 20 h of treatment, the percentage of mobile CB1Rs was 83.0% Ϯ 4.6% (n ϭ 369), 90.3% Ϯ 1.9% (n ϭ 808), and 57.6% Ϯ 8.6% (n ϭ 145) in control, AM281-treated, and WIN-treated neurons, respectively. Thus, the remarkable shift in the distribution of diffusion coefficients toward lower values observed after prolonged agonist exposure is due to an increase in the fraction of immobile receptors.
Moderate Desensitization Is Sufficient to Reduce CB1R Surface Mobility. We tested the effects of short agonist treatments on CB1R lateral mobility. Cortical neurons were incubated for 30 min or 2 h with the agonist WIN, the antagonist AM281, or vehicle. Thirty minutes of treatment had no consequence on CB1R mobility (Fig. S2) . In contrast, a 2-h treatment with the cannabinoid agonist diminished CB1R mobility: the diffusion coefficients of all CB1Rs were lowered (control: median ϭ 0. WIN: median ϭ 0.169 m 2 /s, IQR ϭ 0.088-0.247 m 2 /s, n ϭ 148; P Ͼ 0.05). In contrast, the 2-h agonist treatment significantly reduced the percentage of mobile CB1Rs: in vehicletreated cultures, 89.7% Ϯ 1.7% (n ϭ 434) of CB1Rs were mobile, whereas after agonist exposure, this number dropped to 75.9% Ϯ 4.7% (n ϭ 194; Fig. 2D ). After short agonist treatment, the apparent reduction in the mobility was due to a decrease in the fraction of mobile receptors. Fig. 3A ). AM281 also blocked agonist-induced reduction of CB1R mobility (Fig. 3B ): there were 75.5% Ϯ 2.7% (n ϭ 1,174), 50.4% Ϯ 4.4% (n ϭ 617), and 79.0% Ϯ 5.0% (n ϭ 1,708) mobile receptors in control, WIN, and WIN plus AM281, respectively. Thus, CB1Rs mediate the effects of the CB agonist.
CB1R Desensitization Does Not Alter the Mobility of AMPARs. AMPARs underlie most of the excitatory currents at glutamatergic excitatory synapses, and we have studied extensively their movements on neuronal membranes (4, 5, 22, 23) . We tested the impact of subchronic treatment with either the CB agonist or the CB1R antagonist on the mobility of GluR2-containing AMPARs. Such treatments had no effect on the mobility of GluR2-containing AMPARs (Fig. 3 C and D) , strongly suggesting that CB1R desensitization does not result in a general alteration of neurotransmitter receptor surface movements.
Desensitization Excludes CB1R from Synapses. During desensitization, the fraction of immobile receptors increased significantly. The synaptic terminal is composed of several subcompartments with different functional specialization (24) . Are the CB1Rs within these compartments affected equally by agonist treatment? We compared the effects of CB1R desensitization on the mobility of CB1Rs in the extrasynaptic and synaptic compartments. Both 2 h and 20 h of agonist-induced desensitization reduced the fraction of synaptic CB1Rs (Fig. 4A) . Agonist treatment reduced by as much as 60% the fraction of synaptic CB1Rs. In vehicle-treated neurons, 3% of CB1Rs (Ϯ0.6%, n ϭ 434) were in synapses. Less than 1% of CB1Rs (0.7% Ϯ 0.2%, n ϭ 194) remained within synapses after 2 h of agonist treatment. The CB1R antagonist AM281 had no effect on the number of synaptic receptors (2.9% Ϯ 0.6%, n ϭ 785). There were 3.8% Ϯ 0.8% (n ϭ 369), 2.9% Ϯ 0.6% (n ϭ 808), and 1.3% Ϯ 0.9% (n ϭ 145) synaptic receptors after 20 h of vehicle, AM281, and WIN treatment, respectively. Thus, agonist exposure caused a remarkable reduction in synaptic CB1Rs.
To determine whether the synaptic residency time and the exchange of CB1Rs between synaptic and extrasynaptic compartments altered by CB1R desensitization, we quantified the synaptic dwell time of CB1R agonist-treated cultures. Twenty hours of WIN treatment did not change the residency time of CB1Rs in the synapse (control: dwell time ϭ 0.2 Ϯ 0.05 s, n ϭ Similarly, the exchange rate of CB1Rs between synaptic and extrasynaptic compartments was not affected. The percentages of mobile CB1Rs that alternated between synaptic and extrasynaptic membrane were 19% Ϯ 2.9% (n ϭ 1,016) in control conditions and 21.9% Ϯ 5.3% after agonist exposure (n ϭ 343; P Ͼ 0.05). We found that CB1R desensitization was characterized by a selective decrease in the diffusion coefficients of extrasynaptic CB1Rs (Fig. 4C) . In control conditions, the diffusion coefficients of all CB1Rs in the extrasynaptic (median ϭ 0. Our data are consistent with a model where agonist-induced desensitization affects the mobility of CB1Rs by diminishing the number of surface CB1Rs, reducing the fraction of synaptic CB1Rs, and augmenting the fraction of immobile CB1Rs in the extrasynaptic compartment (Fig. 4D) .
Discussion
The significant therapeutic potential of drugs acting on the eCB system and the fact that CB1R is the principal molecular target of the most widely used illegal drug (marijuana) have generated great interest in the elucidation of the eCB system (1, 3, 25) .
Here, single-quantum dot imaging was combined with pharmacological approaches to identify how agonist desensitization has an impact on the surface movements of native CB1Rs and controls their behavior in cortical synapses in vitro. We present evidence that a presynaptic receptor, CB1R, displays significant movements within axon terminals. Together, the results are consistent with the broad notion that receptor mobility plays a major role in regulating the functions of presynaptic receptors. Our data indicate that agonist desensitization has an impact on the mobility of axonal CB1Rs and results in their synaptic exclusion.
Mobility of Presynaptic CB1Rs. Receptor trafficking regulates synaptic transmission (4, 26) . Trafficking of AMPARs in and out of the synapses is one of the core mechanisms underlying the expression of long-term plasticity (26) . The discovery that surface neurotransmitter receptors are mobile and rapidly exchange in and out of the postsynaptic specialization provides synapses with an additional means to quickly control their gain (4, 5, 23) . Constitutive endocytosis of CB1R in somatodendritic membranes participates in their polarized distribution (21, (27) (28) (29) (30) . In accord with their inhibitory functions, the majority of surface CB1Rs are located in the axonal compartment and the presynaptic terminal (31, 32) . Until the present study, the mobility of presynaptic receptors has never been evaluated. Surface CB1Rs are remarkably dynamic: Ϸ80% of all CB1R were mobile, a value substantially higher than that reported for postsynaptic ionotropic receptors (12, 33) . Similarly to other postsynaptic receptors (5) diffusive movement within the synaptic and extrasynaptic compartments. The short synaptic dwell time of CB1Rs compared with postsynaptic AMPARs (12, 13) may be due to intrinsic receptor properties, differences in anchoring, and interacting partner proteins, and more generally to the marked structural differences in presynaptic and postsynaptic specializations. In accord with the concept that receptor dynamics reflect the features of their immediate surroundings, extrasynaptic (i.e., axonal) CB1R behaviors indicated free diffusive movement, whereas CB1Rs displayed more confined movement within the spatially restricted synaptic domain.
Desensitization Has an Impact on CB1R Mobility. During chronic consumption of cannabis derivatives, such as marijuana, CB1Rs show a marked tolerance (17) (18) (19) . Desensitized CB1Rs are internalized via the clathrin-coated pit pathway. The dynamics of the CB1Rs that remain on the neuronal surface after desensitization have never been explored. We found that a reduction in the mobility of CB1Rs reflects agonist-induced desensitization. This effect was due to a massive increase in the fraction of immobile CB1Rs and not a global reduction in the diffusion of mobile CB1Rs, showing that agonist-induced desensitization controls discrete features of CB1R dynamics.
Desensitization Excludes Surface CB1Rs from the Synaptic Terminal.
The eCB system is a retrograde signaling system where eCBs produced in the postsynapse cross the synaptic cleft, bind to presynaptic CB1Rs, and inhibit transmitter release (3) . A unique in vivo exposure to ⌬ 9 -tetrahydrocannabinol causes a reversible loss of CB1R function that is not due to CB1R internalization or uncoupling (8, 16) . The present data identify a mechanism allowing synapses to efficiently reduce CB1R response after agonist activation. Desensitization was accompanied by a marked increase in the fraction of immobile receptors and a selective decrease in the diffusion coefficients of extrasynaptic CB1Rs. The data show that desensitized CB1Rs are gradually slowed down and immobilized in the extrasynaptic zone, resulting in a progressive loss of synaptic CB1Rs. The functional characteristics of immobilized CB1Rs are unknown, but an exciting hypothesis is that they are incompetent in signaling. In all cases, it is likely that receptors outside the synapse receive fewer signaling eCBs than their synaptic counterparts.
Conclusions
Our data shed light on the dynamic behavior of native presynaptic CB1Rs and suggest that subtle regulations of CB1R movements participate in the complex molecular cascade underlying agonist-induced desensitization. The presently revealed mechanism has significant implications for the study of mechanisms underlying tolerance of other presynaptic GPCRs.
Materials and Methods
Cortical Cell Culture. Cultures of cortical neurons were prepared from Swiss mice (Janvier). On the day of birth the pups were killed by cervical dislocation under isoflurane anesthesia. Dissected cortices were dissociated with the use of papain and were finally triturated mechanically. Cells were plated at a density of 360,000 cells per mL and grown on poly-L-lysine-coated coverslips in MEM supplemented with Serum Supreme (BioWhittaker).
Pharmacological Treatments. The reagents were added to the culture medium 30 min, 2 h, or 20 h before the experiment at the following concentrations: 400 nM WIN and 400 nM AM281, DMSO (1:1,000).
Immunocytochemistry. For live surface CB1R staining, neurons were briefly rinsed in PBS (160 mM NaCl, 10 mM Hepes, 10 mM glucose, 2.4 mM KCl, and 1.5 mM CaCl2) and incubated for 15 min with polyclonal antibodies raised against the N terminus of the CB1 receptor (1:1,000; gift from K. Mackie, Indiana University, Bloomington, IN), fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, bathed in a blocking buffer (0.5% BSA in PBS), and then incubated overnight at 4°C with the other primary antibodies diluted in blocking buffer. After washing, cells were incubated with secondary antibodies for 90 min, washed, and mounted on glass coverslips with AquaPolyMount (Polysciences). Polyclonal CB1R antibodies were visualized with Alexa 488-conjugated anti-rabbit IgG (Invitrogen). The monoclonal anti-MAP2 (1:500), anti-Tau1 (1:500), and anti-GAD65 (1:500) antibodies were revealed with an Alexa 568-conjugated anti-mouse IgG.
Microscopy. Micrographs of immunolabeling with MAP2, Tau1, and GAD65 antibodies were acquired with an epifluorescence microscope (Leica DMR video microscope; oil immersion 40ϫ, N.A. 1.25 objective). Single-particle tracking was performed at 32°C with an inverted microscope (Olympus IX71) equipped with an oil immersion 100ϫ, N.A. 1.35 objective. QDots and MitoTracker were illuminated with a mercury lamp (Olympus) and detected by using appropriate excitation (HQ560/55, HQ480/40) and emission (D655/20, HQ535/50) filters (Chroma Technology). A total of 1,500 consecutive frames were acquired at 20 Hz with an EM-CCD camera QuantEM (20 Hz) or with a CCD camera CoolSNAP HQ (2.5 Hz; Figs. 2 and 4A) (Photometrics).
Single-Particle (Qdot) Tracking. Polyclonal CB1R N-terminus-specific antibodies were incubated with QDot 655 F(abЈ) 2 anti-rabbit (Thermo Fisher Scientific) in PBS for 2 h. The incubation was then blocked with casein for 30 min. CB1R antibodies coupled to QDots655 (CB1R-QD655) were filtered through a column of Superdex 200 gel (Amersham Biosciences). The same protocol was applied for monoclonal anti-GluR2 antibodies (Chemicon) coupled with QDot 655 F(abЈ) 2 anti-mouse.
Neurons were incubated with CB1R-QD655 or GluR2-QD655 for 10 min at 37°C, washed, and incubated for 1 min with a synaptic marker MitoTracker (20 nM; Invitrogen). After the final wash, coverslips were mounted in a chamber with permanent perfusion of a recording medium (160 mM NaCl, 10 mM Hepes, 10 mM glucose, 2.4 mM KCl, and 1.5 mM CaCl 2). To avoid recording of internalized CB1Rs, all of the movies were taken within 20 min. Control experiments performing acid stripping (pH 2.8, 4 min, 4°C) did not show internalized CB1R-QD655 after 20 min of incubation (data not shown) (34) .
Trajectory Analysis. The CB1R-QD655 or GluR2-QD655 recording sessions were processed with MetaMorph software (Universal Imaging). As previously described (12) , the spatial distribution of the signals of the CCD is fitted to a 2-dimensional Gaussian surface. The 2-dimensional trajectories of single molecules in the plane of focus were constructed by correlation analysis between consecutive images using a Vogel algorithm. Tracking of single QDots was performed with custom software written with Matlab (Mathworks). The MSD was calculated according to ͗r 2 ͘ ϭ [͚ iϭ1
NϪn (Xiϩn Ϫ Xi) 2 ϩ (yiϩn Ϫ yi) 2 /N Ϫ n]dt for reconnected trajectories. The diffusion coefficient (D) was calculated from linear fits of the first 4 points of MSD curves versus time using MSD(t) ϭ ͗r 2 ͘(t) ϭ 4Dt. To assign synaptic localization, trajectories were sorted into extrasynaptic and synaptic by using the mitochondria marker MitoTracker image (9 -11): MitoTracker-positive pixels defined the synaptic zone (11) . Synapse dwell time was calculated as a mean residency time of CB1R-QD655 within synapses. All of the trajectories of CB1R that did not leave the synapse during the imaging period were excluded.
